#Genomics Market share

[industrynewsupdates]

Genomics Market Business Growth, Opportunities and Forecast 2024-2030

The global genomics market size was valued at USD 32.65 billion in 2023 and is projected to witness a compound annual growth rate (CAGR) of 16.5% from 2024 to 2030. 

The growth of genomics market is attributed to factors such as growing demand for gene therapy, personalized medicine, drug discovery, increasing cancer incidence, and a significant increase in demand for consumer genomics in recent years. Moreover, increasing number of joint ventures and partnerships amongst market players is also expected to have a positive impact on the genomics market growth. For instance, in June 2022, Illumina, Inc., and Allegheny Health Network signed a collaboration for effective evaluation of the impact of in-house Comprehensive Genomic Profiling (CGP) to leverage patient care.

Gather more insights about the market drivers, restrains and growth of the Genomics Market 

The COVID-19 pandemic outbreak had posed challenges to applications of genomics technology in terms of research and therapeutics. Nevertheless, some niche applications were of great use to mankind during the pandemic situation to facilitate immediate attention for designing effective diagnostics, effective therapeutics and steps to curb the spread of COVID-19.  For example, the viral genome mutational rate (~1-2 bases per month) was gauged for validity of PCR cycle was estimated to understand the efficacy of the re-purposed anti-viral treatments and thereby the vaccine development process was streamlined.

Many genomic surveillance programs were launched country wise to understand the dynamics of pandemic situation and to effective preventive measures. For instance, in December 2020, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) was launched by the joint efforts of Department of Biotechnology (DBT), Ministry of Health, and ICMR with an aim to screen the genomic variations in the SARS-CoV-2 by sequencing technologies. Furthermore, country specific companies are providing consumer genomics services which is also expected to fuel the market size in coming years. One such company being Mapmygenome which is one of the pioneers in India offers DTC genomics services.

The increasing prevalence of inherited cancers is expected create a high demand for cancer genomics. The substantial understanding of human genome have targeted focus on use of various gene therapies for treatment of cancers by modern gene editing techniques such as CRISPR-Cas gene technology. For instance, in September 2022, a group of researchers at the University of California introduced the applications of precision genome editing agents for management of inherited retinal diseases (IRDs).

The development of high-throughput sequencing technologies such as Next-Generation Sequencing (NGS) and microarrays has generated massive amounts of genomic data. However, the rapid accumulation of this data from DNA sequencing and Electronic Health Records (EHRs) poses significant challenges and opportunities for the extraction of biologically or clinically relevant information. Phenome-wide association study (PheWAS) & genome-wide association study (GWAS) are helping researchers to study correlations between genotype and phenotype.

The market players are extensively working towards collaborations, expansions, acquisitions and huge capital investments to advance in research to understand rare diseases and to aid drug discovery. For instance, PacBio declares a collaboration with the Genomics England society for the utility of PacBio’s technology to detect genetic variation in unexplained rare disorders. The study is intended to re-sequence a selection of samples collected during Genomics England’s 100,000 genomes project to discover potential operational and clinical benefits of long-read sequencing for the identification of mutations associated with rare diseases.

Genomics Market Segmentation

Grand View Research has segmented the global genomics market based on application, technology, deliverables, end-use, and region:

Application & Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Functional Genomics

• Transfection

• Real-Time PCR

• RNA Interference

• Mutational Analysis

• SNP Analysis

• Microarray Analysis

• Epigenomics

• Bisulfite Sequencing

• Chromatin Immunoprecipitation (ChIP & ChIP-Seq)

• Methylated DNA Immunoprecipitation (MeDIP)

• High-Resolution Melt (HRM)

• Chromatin Accessibility Assays

• Microarray Analysis

• Pathway Analysis

• Bead-Based Analysis

• Microarray Analysis

• Real-time PCR

• Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)

• Biomarker Discovery

• Mass Spectrometry

• Real-time PCR

• Microarray Analysis

• Statistical Analysis

• Bioinformatics

• DNA Sequencing

• Others

Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Sequencing

• PCR

• Flow Cytometry

• Microarrays

• Other technologies

Deliverables Outlook (Revenue, USD Billion, 2018 - 2030)

• Products

o Instruments/Systems/Software

o Consumables & Reagents

• Services

o NGS-based Services

o Core Genomics Services

o Biomarker Translation Services

o Computational Services

o Others

End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Clinical Research

• Academic & Government Institutes

• Hospitals & Clinics

• Pharmaceutical & Biotechnology Companies

• Other End Users

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o India

o Japan

o South Korea

o Australia

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global cell sorting market size was valued at USD 242.7 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2030. 

• The global live cell imaging market size was valued at USD 2.48 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2030.

Key Companies & Market Share Insights

The market players operating in the genomics market are adopting product approval to increase the reach of their products in the market and improve the availability of their products & services in diverse geographical areas, along with expansion as a strategy to enhance production/research activities. In addition, several market players are acquiring smaller players to strengthen their market position. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies.

Key Genomics Companies:

• Agilent Technologies

• Bio-Rad Laboratories, Inc.

• BGI Genomics

• Color Genomics, Inc.

• Danaher Corporation

• Eppendorf AG

• Eurofins Scientific

• F. Hoffmann-La Roche Ltd.

• GE Healthcare

• Illumina, Inc.

• Myriad Genetics, Inc.

• Oxford Nanopore Technologies

• Pacific Biosciences of California, Inc.

• QIAGEN N.V.

• Quest Diagnostics Incorporated

• Thermo Fisher Scientific, Inc.

• 23andMe, Inc.

Recent Development

• In November 2023, Fabric Genomics collaborated with DNAnexus and Oxford Nanopore Technologies for deployment of CLIA/CAP labs in pediatric and neonatal ICU’s. The labs will use Oxford Nanopore’s platforms to study genetic disorders in infants.

• In February 2023, Illumina, Inc. entered into a collaboration with African Centre of Excellence for Genomics of Infectious Diseases to start a training institute to increase genomic capabilities in African region

• In January 2023, SOPHiA GENETIC collaborated with the Memorial Sloan Kettering Cancer Center (MSK), a U.S. Cancer Center, to offer researchers and clinicians solutions to expand analytical and testing capabilities.

• In January 2023, Agilent Technologies, Inc. announced acquisition of Avida Biomed, a company that develops target enrichment workflows for clinical researchers utilizing NGS methods to study cancers.

• In April 2022, QIAGEN launched the Biomedical Knowledge Base in Europe, Japan, North America, and Australia to support data science applications in biotech companies 

Order a free sample PDF of the Genomics Market Intelligence Study, published by Grand View Research.

[trendingreportz]

Genomics Market - Forecast(2024 - 2030)

Global Genomic Market Overview:

A genome is the genetic material of an organism. It includes both the genes and the noncoding DNA, as well as mitochondrial DNA and chloroplast DNA. The study of genomes is called genomics. The genomics market is gaining traction owing to its applications in various fields of study such as intragenomic phenomenon including epistasis, pleiotropy, heterosis, and other interactions between loci and alleles within the genome. In this era of medical and life science innovations shaping itself as an inevitable uptake for sustainability of mankind, the genomic research is poised for exponential growth owing to imperative genetic innovations feeding off it. Abundant potential has driven this arcade to reach a staggering market size of $16 billion - $16.5 billion as of 2018, and the demand is estimated to increment at formidable CAGR of 9.2% to 10.2% during the forecast period of 2019 to 2025.

Request Sample

Global Genomic Market Outlook:

Genomics is extensively employed in healthcare, agriculture, biotechnology, DNA sequencing, and diagnostics. In the healthcare segment, genomics is used for the development of vaccines and drugs. This segment leads the application vertical and is growing with a CAGR of 10.1%-10.7 % through to 2025. Genomics plays a significant part in diagnosis of several genetic disorders. It has an ample scope in personalized medication as it can advocate a medical management constructed on the genetic face of a person with the help of clinical data and AI.  It is also applied in synthetic biology and bioengineering. Genomics research in agriculture is hired for plant breeding and genetics to cultivate crop production. The understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant will aid the plant breeders to identify the traits and then manipulate those traits to obtain a high yield. All these factors affecting the enormous medical and agricultural sector are all set to stroke the genomics market with abundant demand.

Inquiry Before Buying

Global Genomic Market Growth Drivers:

As per the National Center for Biotechnology Information, U.S, the progression in oncology (study and treatment of tumor) expenses is forecast to rise 7%–10% annually throughout 2020, with universal oncology cost exceeding $150 billion[1]. As per the WHO, cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018[2]. And the total annual economic cost of cancer at the initial period of this decade was estimated at approximately $1.16 trillion. Thus the application of genomics in exploring cell-free circulating DNA by several R&D sectors as a potential biomarker for cancers is driving the market towards exponential growth. The genomics market with its current potential displays all the necessary traits it can adapt in the coming years to divert a huge chunk of traffic and revenue from the omnipresent cancer diagnostics.

As per the Food and Agriculture Organization of United Nations, between 1960 and 1990 the arable land increased by 1.5 billion ha, and in the recent past decades the elevation recorded is just 155 million ha[3]. With decreasing arable floor and the increasing global population augmenting the demand for food by 70% (by 2050), obtaining a high yield is a major trend in the agricultural sector. Genomics market is all set to capitalize on this unprecedented demand scenario. Genomics supplements the understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant, thus aiding the plant breeders to identify the traits and then manipulate those traits to obtain a high yield.

After an acute analysis of the regional insights of the global genomics market, North America is revealed to hold 39% to 40% of the entire global market size as of 2018. Such dominance can be attributed to several aspects such as cumulative investment on research by federal administrations, growing patient awareness, and accessibility of urbane healthcare facilities.

Schedule a Call

Global Genomics Market Players Perspective:

Some of other key players profiled in this IndustryARC business intelligence report are Beckton Dickson, Synthetic Genomics Inc. (SGI) ,Cepheid, Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, GE Healthcare, Illumina, Inc., Danaher Corporation,F. Hoffmann-La Roche, QIAGEN, Thermo Fisher Scientific and PacBio (Pacific Biosciences of California). Majority of the companies mentioned are situated in North America augmenting the regional affluence in the global market.

Global Genomics Market Trends:

High overload owing to a wide range of reagents and consumables has propelled companies into approving different policies to endure in the market and stay ahead of the curve.

For instance, in January 2017, BD launched Precise WTA Reagents for precise and guileless quantification of hereditary data form single cell analysis. Moreover, in July 2016, SGI-DNA entered into a distribution agreement with VWR International, an American company involved in the distribution of research laboratory products, with over 1,200,000 items to more than 250,000 customers in North America and Europe.

Genomics Market Research Scope

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Genomics Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of equipment in the Genomics Market, and their specific applications in different phases of industrial operations.

Buy Now

Genomics Market Report: Industry Coverage

Types of Solutions Genomics Market:

By Product Types- Microarray chip, Sequencers.

By Application- Genotyping, SNP analysis.

By End-User- Anthropology, Diagnostics.

The Genomics Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

[alicetleibowitz]

Explore the dynamic landscape of the Genomics market, where cutting-edge technologies converge with healthcare innovation to unlock the mysteries of our genetic blueprint.

[trendingrepots]

Genomics Market - Forecast(2024 - 2030)

Global Genomic Market Overview:

Genomics Market Size is forecast to reach $ 104990.0 Million by 2030, at a CAGR of 12.4% during forecast period 2024-2030. A genome is the genetic material of an organism. It includes both the genes and the noncoding DNA, as well as mitochondrial DNA and chloroplast DNA. The study of genomes is called genomics. The genomics market is gaining traction owing to its applications in various fields of study such as intragenomic phenomenon including epistasis, pleiotropy, heterosis, and other interactions between loci and alleles within the genome. In this era of medical and life science innovations shaping itself as an inevitable uptake for sustainability of mankind, the genomic research is poised for exponential growth owing to imperative genetic innovations feeding off it. Abundant potential has driven this arcade to reach a staggering market size of $16 billion - $16.5 billion as of 2018, and the demand is estimated to increment at formidable CAGR of 9.2% to 12.4% during the forecast period of 2024 to 2030.

 𝐃����𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞

Global Genomic Market Outlook:

Genomics is extensively employed in healthcare, agriculture, biotechnology, DNA sequencing, and diagnostics. In the healthcare segment, genomics is used for the development of vaccines and drugs. This segment leads the application vertical and is growing with a CAGR of 10.1%-10.7 % through to 2025. Genomics plays a significant part in diagnosis of several genetic disorders. It has an ample scope in personalized medication as it can advocate a medical management constructed on the genetic face of a person with the help of clinical data and AI.  It is also applied in synthetic biology and bioengineering. Genomics research in agriculture is hired for plant breeding and genetics to cultivate crop production. The understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant will aid the plant breeders to identify the traits and then manipulate those traits to obtain a high yield. All these factors affecting the enormous medical and agricultural sector are all set to stroke the genomics market with abundant demand.

Global Genomic Market Growth Drivers:

As per the National Center for Biotechnology Information, U.S, the progression in oncology (study and treatment of tumor) expenses is forecast to rise 7%–10% annually throughout 2020, with universal oncology cost exceeding $150 billion[1]. As per the WHO, cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018[2]. And the total annual economic cost of cancer at the initial period of this decade was estimated at approximately $1.16 trillion. Thus the application of genomics in exploring cell-free circulating DNA by several R&D sectors as a potential biomarker for cancers is driving the market towards exponential growth. The genomics market with its current potential displays all the necessary traits it can adapt in the coming years to divert a huge chunk of traffic and revenue from the omnipresent cancer diagnostics.

As per the Food and Agriculture Organization of United Nations, between 1960 and 1990 the arable land increased by 1.5 billion ha, and in the recent past decades the elevation recorded is just 155 million ha[3]. With decreasing arable floor and the increasing global population augmenting the demand for food by 70% (by 2050), obtaining a high yield is a major trend in the agricultural sector. Genomics market is all set to capitalize on this unprecedented demand scenario. Genomics supplements the understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant, thus aiding the plant breeders to identify the traits and then manipulate those traits to obtain a high yield.

After an acute analysis of the regional insights of the global genomics market, North America is revealed to hold 39% to 40% of the entire global market size as of 2018. Such dominance can be attributed to several aspects such as cumulative investment on research by federal administrations, growing patient awareness, and accessibility of urbane healthcare facilities.

[marketwire]

Single-cell Genome Sequencing Market - Forecast(2024 - 2030)

Single-cell Genome Sequencing Market Overview 

The Single-cell Genome Sequencing size is estimated to reach $9 billion by 2030, growing at a CAGR of 16.2% during the forecast period 2023-2030. Single-cell genome sequencing is one of the major areas of research for finding a cure for chronic ailments such as cancer. The rising cases of cancer worldwide would drive the Single-cell Genome Sequencing Market during the forecast period. According to Cancer.org, the global burden of new cancer cases would grow to 27.5 million by 2040. This would certainly boost the demand for Single-cell Genome Sequencing Market to find a cure for such chronic diseases.

Rapid development in sequencing technologies is also expected to drive the growth of this market during the forecast period. Polymerase chain reaction (PCR) and next-generation sequencing are emerging as the preferred technologies for various applications, especially for single-cell genomic sequencing. In January 2022, a group of medical Scientists at Stanford and their collaborators developed a new ultra-fast genome sequencing approach that offered a diagnostic rate of about 12% higher than the average rate for diagnosing mystery illnesses.

COVID-19 / Ukraine Crisis - Impact Analysis: 

The COVID-19 pandemic had a positive impact on the Single-cell Genome Sequencing Market. The studies on single-cell genome sequencing offered critical insights into coronavirus infection and allowed medical experts better understand the nature of the infection. On performing single-cell sequencing, most cell types in patients with COVID-19 showed a significant interferon-α response along with an overall acute inflammatory response.

 Russia’s invasion of Ukraine has made a significant impact on the Single-cell Genome Sequencing market. It has not only affected the lives and work of genomic researchers in these countries but has also influenced the relationships with colleagues in the U.S. and elsewhere.

The sanctions against Russia are most likely to bring experimental genomics research in the country to a halt. Ukraine had several genomics research projects going on before the war began. Now, with all the unrest, most researchers in Ukraine are fleeing the country and looking for positions in the west.

Request Sample

Key Takeaways:

Fastest Growth in the Asia-Pacific Region : Geographically, in the global Single-cell Genome Sequencing market share, Asia-Pacific is analyzed to grow with the highest CAGR of 17.2% during the forecast period 2023-2030. This growth is driven by the rising number of cancer cases in the region. According to the projections by the International Agency for Research on Cancer, there would be about 15.1 million new cases per year in Asia until 2040. The unprecedented rate of population aging is the key determinant of this development. Japan, the country with the oldest population in the world, also has the highest rate of cancer. This would drive growth in the Single-cell Genome Sequencing Market in the region during the forecast period.

Reagents Segment to Register the Fastest Growth : In the Single-cell Genome Sequencing analysis, the Reagents segment is estimated to grow with the highest CAGR of 17% during the forecast period. This is because the use of single-cell sequencing reagents allows the experts to process bulk samples with the input of as few as 100 cells. With the recent advancements in single-cell DNA sequencing techniques, bulk DNA sequencing can be done more efficiently and cost-effectively. Moreover, commercial reagents are now available for all the wet-lab steps of a scRNA-seq protocol as well as for preparing barcoded cDNA libraries. The increasing availability of reagents and their growing need in various single-cell genome sequencing processes are boosting its growth in the Single-cell Genome Sequencing Market during the forecast period.

Academic and Research Laboratories Segment is Leading the Market : According to the Single-Cell Genome Sequencing Market forecast, the academic and research laboratories segment held the largest market share of 38.6% in 2022. Single-cell genomics is emerging as one of the major areas in scientific research and development. The rising prevalence of chronic diseases demands new cures and treatment options, which is further boosting the growth of the academic and research laboratories segment. Moreover, understanding the genomics of individual cells opens up a new set of opportunities for the world of biotechnology.

Increased Funding for Vaccine Development and Production : Government agencies in various parts of the world have increased funding for the development and production of vaccines in response to the pandemic. This has led to increased use of single-cell analysis (SCA) tools for COVID-19 research. SCA helps in the assessment of the peripheral immune function of the disease and contributes to the study of the pathophysiology and treatment possibilities of the disease. Thus, the market is positively impacted by COVID-19.

Massive Demand in the field of Immunology, Oncology and Others : Single-cell technology is used in the molecular-level examination of processes and pathways of cellular heterogeneity along with its assessment. This rapidly developing technology has major applications in immunology, oncology and other major areas. Moreover, the development of advanced tools that help make proteomic and transcriptomic processes simpler is also driving the use of single-cell analysis methods, boosting the growth of the Single-cell Genome Sequencing Market.

High Cost of Instruments to Hinder Market Growth : While there is a significant demand for genome sequencing machines among the end-user industries, the instrument costs are significantly high. According to a report published in Bloomberg, Illumina’s new NovaSeq X series costs $985,000 for the base machine and $1.25 million for the advanced one. Such high cost of instruments are likely to hinder the growth of the Single-cell Genome Sequencing Market.

Inquiry Before Buying

Key Market Players:

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Single-Cell Genome Sequencing Market. The top 10 companies in this industry are listed below:

Standard BioTools Inc. (Maxpar®, Advanta™ Assays)

QIAGEN N.V. (QIAseq FX, REPLI-g)

Illumina, Inc. (NovaSeq, NextSeq)

F. Hoffmann-La Roche AG (AVENIO, MagNA Pure)

Thermo Fisher Scientific, Inc. (Invitrogen, Applied Biosystems)

Bio-Rad Laboratories, Inc. (SEQuoia, ddSEQ)

10X Genomics, Inc. (Chromium, Visium)

Becton, Dickinson and Company (BD Rhapsody™, BD AbSeq)

Oxford Nanopore Technologies Limited (MinION, GridION)

Beijing Genomics Institute Group (CardioGen, COLOTECT™)

[lalsingh228-blog]

Artificial Intelligence In Genomics Market May Set New Epic Growth Story

The global Artificial Intelligence In Genomics market focuses on encompassing major statistical evidence for the Artificial Intelligence In Genomics industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Artificial Intelligence In Genomics study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.

Key players in the global Artificial Intelligence In Genomics marketIBM Corporation (United States), Microsoft Corporation (United States), NVIDIA Corporation (United States), Deep Genomics (Canada), BenevolentAI (United Kingdom), Fabric Genomics Inc. (United States), Verge Genomics (United States), Cambridge Cancer Genomics (United Kingdom), Sophia Genetics (United States), Data4Cure Inc. (United States). Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/173521-global-artificial-intelligence-in-genomics-market Although genomic medicine has achieved great advances in recent years, the clinical use of genomics is still evolving as new understanding and technology emerge. One key problem is making sense of exceptionally huge amounts of genomic sequence data and properly integrating and examining it with other relevant information, such as other molecular or clinical data. AI-based computer vision methods are set to change image-based diagnostics in clinical diagnostics, while other AI subtypes have begun to show comparable promise in diverse diagnostic modalities. Deep learning is a sort of AI technique that is used to handle vast and complicated genomic datasets in particular fields, such as clinical genomics.What's Trending in Market:

Rising Adoption of AI in Precision Medicine Segment

Challenges:

Data Theft or Leakage

High Initial Investment

Market Growth Drivers:

High Investments in AI for Genomics

Growth in Healthcare Infrastructure

The Artificial Intelligence In Genomics industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedent growth trajectory for the Artificial Intelligence In Genomics market. The report also focuses on a comprehensive market revenue streams along with growth patterns, Local reforms, COVID Impact analysis with focused approach on market trends, and the overall growth of the market.Moreover, the Artificial Intelligence In Genomics report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Artificial Intelligence In Genomics market, business trends, potential revenue sources, and upcoming market opportunities.

Download PDF Sample of Artificial Intelligence In Genomics Market report @ https://www.advancemarketanalytics.com/download-report/173521-global-artificial-intelligence-in-genomics-market The Global Artificial Intelligence In Genomics Market segments and Market Data Break Down are illuminated below: by Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & Animal Research, Other), Technology (Deep Learning, Reinforcement Learning, Supervised Learning, Unsupervised Learning, Others), End Use (Hospitals, Specialty Clinics), Functions (Genome Sequencing, Gene Editing, Clinical Workflows, Predictive Genetic Testing), Component (Software, Services (Managed, Professional)) The Artificial Intelligence In Genomics market study further highlights the segmentation of the Artificial Intelligence In Genomics industry on a global distribution. The report focuses on regions of LATAM, North America, Europe, Asia, and the Rest of the World in terms of developing market trends, preferred marketing channels, investment feasibility, long term investments, and business environmental analysis. The Artificial Intelligence In Genomics report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.In addition, the Artificial Intelligence In Genomics market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Artificial Intelligence In Genomics market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Artificial Intelligence In Genomics industry as it explores the competitive nature of the market complete with a regional analysis.

Brief about Artificial Intelligence In Genomics Market Report with TOC @ https://www.advancemarketanalytics.com/reports/173521-global-artificial-intelligence-in-genomics-market Some Point of Table of Content:Chapter One: Report OverviewChapter Two: Global Market Growth TrendsChapter Three: Value Chain of Artificial Intelligence In Genomics MarketChapter Four: Players ProfilesChapter Five: Global Artificial Intelligence In Genomics Market Analysis by RegionsChapter Six: North America Artificial Intelligence In Genomics Market Analysis by CountriesChapter Seven: Europe Artificial Intelligence In Genomics Market Analysis by CountriesChapter Eight: Asia-Pacific Artificial Intelligence In Genomics Market Analysis by CountriesChapter Nine: Middle East and Africa Artificial Intelligence In Genomics Market Analysis by CountriesChapter Ten: South America Artificial Intelligence In Genomics Market Analysis by CountriesChapter Eleven: Global Artificial Intelligence In Genomics Market Segment by TypesChapter Twelve: Global Artificial Intelligence In Genomics Market Segment by Applications

Buy the Latest Detailed Report @ https://www.advancemarketanalytics.com/buy-now?format=1&report=173521 Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, West Europe or Southeast Asia.

Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com Connect with us at https://www.linkedin.com/company/advance-market-analytics https://www.facebook.com/AMA-Research-Media-LLP-344722399585916 https://twitter.com/amareport

[rohanisblog]

The Global Genomic Testing Market was valued at approximately USD 13.7 billion and is projected to attain a valuation of 30.08 billion by 2031, at a CAGR of 9.54% During the Forecast Period, 2023-2031.

Key Players in the Market Report 

Agilent Technologies, Inc.

BGI Group

Bio-Rad Laboratories

Danaher Corporation

Eurofins Genomics

F. Hoffmann-La Roche

Illumina, Inc.

QIAGEN

Singular Genomics Systems, Inc.

Thermo Fisher Scientific, Inc.

Other Prominent players

[vipinmishra]

Analyzing Opportunities in the Global Plant Genomics Market

Adoption of next-generation sequencing technologies and increasing application of genomics in plant breeding is expected to drive the Global Plant Genomics Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Plant Genomics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Plant Genomics Market stood at USD 7.68 Billion in 2022 and is anticipated to grow with a CAGR of 8.26% in the forecast period, 2024-2028. The global plant genomics market is primarily driven by several key factors. First among these is the increasing demand for improved crop varieties. As the global population continues to rise, so does the necessity for high-yield crops that can sustain this growth. Advancements in plant genome sequencing technology and our understanding of plant genomes have considerably expanded, making it possible to alter plant genetics for better resilience and productivity.

The burgeoning interest in sustainable farming practices and climate-resilient crops further bolsters this market. Government and private funding for research in plant genomics has seen a significant uptick, further propelling market growth.

The global plant genomics market is experiencing remarkable growth, driven by rapid advancements in biotechnology and the pressing need for sustainable agriculture practices. As researchers delve deeper into the realm of genomics, they are uncovering new opportunities to enhance plant resilience, improve productivity, and combat malnutrition. By developing crops that are more resistant to pests and diseases, require fewer resources, and possess higher nutritional value, genomics is revolutionizing the way we approach agriculture.

The market is primarily driven by the increasing prevalence of protein deficiency among individuals, leading to a growing demand for protein-rich plants. The market is witnessing a rise in the demand for high-quality fruits, vegetables, and cereals due to the expanding population. Furthermore, extensive research and development (R&D) activities aimed at developing advanced plant genomics methods are fostering a positive outlook for the market. Additionally, favorable initiatives undertaken by government bodies in various countries to promote improved plant and crop growth programs are bolstering the market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Plant Genomics Market.” https://www.techsciresearch.com/report/plant-genomics-market/12878.html

Moreover, the significant loss of vegetative cover has necessitated the adoption of alternative scientific methods to enhance vegetation and increase plant productivity. The market is further propelled by the shifting preference towards genomics over automated instruments, driven by its cost-efficiency and the increasing costs associated with automated instruments. Other factors contributing to the market include the rising demand for a bio-based economy to enhance food security, rapid urbanization, substantial growth in the food and beverage (F&B) industry, the increasing trend of veganism, and a heightened focus on sustainable development.

Moreover, genomics is proving to be a vital tool in addressing the urgent challenges posed by climate change. With its help, scientists are developing climate-smart crops that can thrive in harsh environmental conditions, safeguarding our food supply for the future. By leveraging the power of genomics, we can create a more resilient and sustainable food system that withstands the impacts of a changing climate.

Furthermore, with the increasing global population and evolving dietary preferences, there is a pressing need for high-yield crops that can meet the growing food requirements sustainably. This demand has paved the way for the field of plant genomics, which offers a promising solution. By leveraging the power of plant genomics, scientists and researchers can develop genetically improved crops that not only yield higher quantities but also boast improved nutritional content and enhanced resistance to environmental stresses.

The Global Plant Genomics Market is segmented into type, trait, objective, application, regional distribution, and company.

Based on trait, Disease resistance is undeniably the dominating segment in the agricultural industry, driven by an escalating global demand for high yield crops. These crops not only deliver abundant harvests but also possess remarkable resilience against a wide array of plant diseases. This resilience is achieved through harnessing the power of plant genomics, which enables the enhancement of disease resistance. By leveraging cutting-edge genomic technologies, this segment plays a pivotal role in safeguarding food security and ensuring a sustainable future for generations to come.

The significance of disease resistance in the market is further accentuated by its indispensable contribution to meeting the ever-increasing demands of a growing population. As the world population continues to expand, the need for efficient and resilient crop production becomes paramount. Disease-resistant crops offer a promising solution, reducing the reliance on chemical pesticides and promoting environmentally-friendly agricultural practices.

This not only benefits farmers by reducing crop losses but also contributes to the preservation of ecosystems and biodiversity. Disease resistance is a crucial and transformative aspect of the agricultural industry. Its impact extends far beyond crop yield and profitability, encompassing food security, sustainability, and environmental stewardship. By continually pushing the boundaries of plant genomics research, we can unlock new possibilities and pave the way towards a more resilient and prosperous agricultural future.

Based on region, the Asia Pacific region is at the forefront of the Global Plant Genomics Market, driven by a multitude of factors. Firstly, the surge in population growth in the region has created a pressing need for increased food production. This, in turn, has intensified the demand for efficient crop yield, making plant genomics a critical field of study. Moreover, the Asia Pacific region boasts a diverse range of agro-based economies that are progressively embracing biotechnological advancements in their agricultural practices.

Governments in the region are also providing strong support through funding and research initiatives, further fueling the growth of plant genomics. Additionally, the presence of leading players in genomics and a thriving market for genetically modified organisms (GMO) in countries such as China and India substantiate the region's dominance in the market. With its combination of favorable demographics, technological innovation, and governmental support, the Asia Pacific region continues to shape the future of plant genomics.

Major companies operating in Global Plant Genomics Market are:

Eurofins Scientific SE

Agilent Technologies, Inc.

Illumina, Inc.

NRGene Ltd.

Qiagen NV

Traitgenetics GmbH

Novogene Corporation

Oxford Nanopore Technologies Ltd.

Genewiz, Inc.

Genotypic Technology Pvt Ltd.

Download Free Sample Report https://www.techsciresearch.com/sample-report.aspx?cid=12878

Customers can also request for 10% free customization on this report.

“The future of the global plant genomics market looks highly promising, driven by significant technological advancements and a substantial increase in investment in research and development activities. With the rapid emergence of precision farming and bioinformatics, innovative mapping technologies for plant genomes are expected to flourish, providing breeders with unprecedented opportunities to develop highly improved and resilient plant varieties. This will not only enhance crop yield but also bolster the plants' resistance to various diseases and environmental stressors.

Furthermore, the escalating demand for genetically modified crops (GMOs) to meet the ever-growing global food demand is anticipated to further stimulate the growth of the plant genomics market. As science continues to unravel the secrets of plant genetics, we can expect a bright future for this dynamic and rapidly evolving field.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Plant Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Molecular Engineering, Genetic Engineering, Others), By Trait (Yield Improvement, Disease Resistance, Herbicide Tolerance, Others), By Objective (DNA Extraction & Purification, DNA/RNA Sequencing, Genotyping, GENE Expression Profiling, Marker-Assisted Selection, Others), By Application (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Others), By Region and Competition”, has evaluated the future growth potential of Global Plant Genomics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Plant Genomics Market.

Browse Related Reports

Soil Active Herbicides Market https://www.techsciresearch.com/report/soil-active-herbicides-market/20660.html Fertilizer Additives Market https://www.techsciresearch.com/report/fertilizer-additives-market/20663.html Water Soluble NPK Fertilizers Market https://www.techsciresearch.com/report/water-soluble-npk-fertilizers-market/20667.html

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com

[futuretonext]

USA Genome Sequencing Market- A Story of Rapid Development

According to MarkNtel Advisors’ research report titled “USA Genome Sequencing Market Analysis, 2020”, the USA Genome Sequencing market is anticipated to grow at a considerable CAGR during 2020-25F on an account of bolstering investment in genomics medicine and rising partnerships among the market players to accelerate the adoption of genomics in order to support the increasing demand for clinical grade genomic information at lower cost.

[trendingreportz]

Single-cell Genome Sequencing Market - Forecast(2024 - 2030)

Single-cell Genome Sequencing Market Overview 

The Single-cell Genome Sequencing size is estimated to reach $9 billion by 2030, growing at a CAGR of 16.2% during the forecast period 2023-2030. Single-cell genome sequencing is one of the major areas of research for finding a cure for chronic ailments such as cancer. The rising cases of cancer worldwide would drive the Single-cell Genome Sequencing Market during the forecast period. According to Cancer.org, the global burden of new cancer cases would grow to 27.5 million by 2040. This would certainly boost the demand for Single-cell Genome Sequencing Market to find a cure for such chronic diseases.

Rapid development in sequencing technologies is also expected to drive the growth of this market during the forecast period. Polymerase chain reaction (PCR) and next-generation sequencing are emerging as the preferred technologies for various applications, especially for single-cell genomic sequencing. In January 2022, a group of medical Scientists at Stanford and their collaborators developed a new ultra-fast genome sequencing approach that offered a diagnostic rate of about 12% higher than the average rate for diagnosing mystery illnesses.

Request Sample

Single-cell Genome Sequencing Market - Report Coverage:

The “Single-cell Genome Sequencing Market Report- Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Single-cell Genome Sequencing Market.AttributeSegment

By Product Type

Consumables

Reagents

By Technique

Flow Cytometry

Next-generation Sequencing

Polymerase Chain Reaction

Microscopy

Mass Spectrometry

Others

By Application

Cancer

Immunology

Microbiology

Others

By End-User

Academic and Research Laboratories

Hospitals and Diagnostic Centers

Biotechnology and Pharmaceutical Companies

Cell Banks and IVF Centers

By Geography

North America (the U.S., Canada and Mexico)

Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific),

South America (Brazil, Argentina, Chile, Colombia and the Rest of South America)

The Rest of the World (the Middle East and Africa).

COVID-19 / Ukraine Crisis - Impact Analysis: 

The COVID-19 pandemic had a positive impact on the Single-cell Genome Sequencing Market. The studies on single-cell genome sequencing offered critical insights into coronavirus infection and allowed medical experts better understand the nature of the infection. On performing single-cell sequencing, most cell types in patients with COVID-19 showed a significant interferon-α response along with an overall acute inflammatory response.

 Russia’s invasion of Ukraine has made a significant impact on the Single-cell Genome Sequencing market. It has not only affected the lives and work of genomic researchers in these countries but has also influenced the relationships with colleagues in the U.S. and elsewhere.

The sanctions against Russia are most likely to bring experimental genomics research in the country to a halt. Ukraine had several genomics research projects going on before the war began. Now, with all the unrest, most researchers in Ukraine are fleeing the country and looking for positions in the west.

Inquiry Before Buying

Key Takeaways: 

Fastest Growth in the Asia-Pacific Region : Geographically, in the global Single-cell Genome Sequencing market share, Asia-Pacific is analyzed to grow with the highest CAGR of 17.2% during the forecast period 2023-2030. This growth is driven by the rising number of cancer cases in the region. According to the projections by the International Agency for Research on Cancer, there would be about 15.1 million new cases per year in Asia until 2040. The unprecedented rate of population aging is the key determinant of this development. Japan, the country with the oldest population in the world, also has the highest rate of cancer. This would drive growth in the Single-cell Genome Sequencing Market in the region during the forecast period.

Reagents Segment to Register the Fastest Growth : In the Single-cell Genome Sequencing analysis, the Reagents segment is estimated to grow with the highest CAGR of 17% during the forecast period. This is because the use of single-cell sequencing reagents allows the experts to process bulk samples with the input of as few as 100 cells. With the recent advancements in single-cell DNA sequencing techniques, bulk DNA sequencing can be done more efficiently and cost-effectively. Moreover, commercial reagents are now available for all the wet-lab steps of a scRNA-seq protocol as well as for preparing barcoded cDNA libraries. The increasing availability of reagents and their growing need in various single-cell genome sequencing processes are boosting its growth in the Single-cell Genome Sequencing Market during the forecast period.

Academic and Research Laboratories Segment is Leading the Market : According to the Single-Cell Genome Sequencing Market forecast, the academic and research laboratories segment held the largest market share of 38.6% in 2022. Single-cell genomics is emerging as one of the major areas in scientific research and development. The rising prevalence of chronic diseases demands new cures and treatment options, which is further boosting the growth of the academic and research laboratories segment. Moreover, understanding the genomics of individual cells opens up a new set of opportunities for the world of biotechnology.

Increased Funding for Vaccine Development and Production : Government agencies in various parts of the world have increased funding for the development and production of vaccines in response to the pandemic. This has led to increased use of single-cell analysis (SCA) tools for COVID-19 research. SCA helps in the assessment of the peripheral immune function of the disease and contributes to the study of the pathophysiology and treatment possibilities of the disease. Thus, the market is positively impacted by COVID-19.

Massive Demand in the field of Immunology, Oncology and Others : Single-cell technology is used in the molecular-level examination of processes and pathways of cellular heterogeneity along with its assessment. This rapidly developing technology has major applications in immunology, oncology and other major areas. Moreover, the development of advanced tools that help make proteomic and transcriptomic processes simpler is also driving the use of single-cell analysis methods, boosting the growth of the Single-cell Genome Sequencing Market.

High Cost of Instruments to Hinder Market Growth : While there is a significant demand for genome sequencing machines among the end-user industries, the instrument costs are significantly high. According to a report published in Bloomberg, Illumina’s new NovaSeq X series costs $985,000 for the base machine and $1.25 million for the advanced one. Such high cost of instruments are likely to hinder the growth of the Single-cell Genome Sequencing Market.

Schedule a Call

Key Market Players:

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Single-Cell Genome Sequencing Market.

The top 10 companies in this industry are listed below:

Standard BioTools Inc. (Maxpar®, Advanta™ Assays)

QIAGEN N.V. (QIAseq FX, REPLI-g)

Illumina, Inc. (NovaSeq, NextSeq)

F. Hoffmann-La Roche AG (AVENIO, MagNA Pure)

Thermo Fisher Scientific, Inc. (Invitrogen, Applied Biosystems)

Bio-Rad Laboratories, Inc. (SEQuoia, ddSEQ)

10X Genomics, Inc. (Chromium, Visium)

Becton, Dickinson and Company (BD Rhapsody™, BD AbSeq)

Oxford Nanopore Technologies Limited (MinION, GridION)

Beijing Genomics Institute Group (CardioGen, COLOTECT™)

 Buy Now

Scope of the Report:

Report MetricDetails

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

16.2%

Market Size in 2030

$9 billion

Segments Covered

Product Type, Technique, Application, End-user and Region

Geographies Covered

North America (the U.S., Canada and Mexico) Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and the Rest of the World (the Middle East and Africa).

Key Market Players

Standard BioTools Inc.

QIAGEN N.V.

Illumina, Inc.

F. Hoffmann-La Roche AG

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

10X Genomics, Inc.

Becton, Dickinson and Company

Oxford Nanopore Technologies Limited

Beijing Genomics Institute Group

Pacific Biosciences of California, Inc.

NuGEN Technologies, Inc.

Novogene Co. Ltd.

Takara Bio, Inc.

Danaher Corporation

[myblogscmi]

Global Genomic Cancer Testing Market Is Estimated To Witness High Growth Owing To Increasing Demand For Personalized Medicine

The Global Genomic Cancer Testing Market Is Estimated To Be Valued At US$16.15 Billion In 2023 And Is Expected To Exhibit A CAGR Of 16.1% Over The Forecast Period (2023-2030), As Highlighted In A New Report Published By Coherent Market Insights. A) Market Overview: Genomic Cancer Testing Is A Type Of Diagnostic Testing That Involves Analyzing A Person's Genetic Material To Identify Changes Or Mutations That May Increase The Risk Of Developing Cancer. This Testing Can Help Guide Treatment Decisions, Predict The Likelihood Of Cancer Recurrence, And Identify Targeted Therapies. Genomic Cancer Testing Offers Several Advantages Over Traditional Cancer Testing Methods. It Provides A Comprehensive Analysis Of An Individual's Genome, Allowing For More Accurate Diagnosis And Personalized Treatment Plans. Additionally, It Can Help Identify Individuals Who May Be At Higher Risk For Certain Types Of Cancer, Allowing For Earlier Intervention And Preventive Measures. B) Market Key Trends: One Key Trend In The Genomic Cancer Testing Market Is The Increasing Demand For Personalized Medicine. With Advances In Genomic Sequencing Technologies, Physicians Are Now Able To Tailor Treatments To A Patient's Specific Genetic Profile. This Approach Allows For More Targeted Therapies, Minimizing Side Effects And Improving Overall Patient Outcomes. For Example, Foundation Medicine, A Subsidiary Of Roche, Offers Comprehensive Genomic Profiling Tests That Analyze A Patient's Tumor DNA To Identify Specific Genetic Alterations. This Information Can Then Be Used To Match Patients With Targeted Therapies That Are Most Likely To Be Effective Against Their Specific Mutation. C) PEST Analysis: 1. Political: Government Regulations Play A Crucial Role In The Adoption And Reimbursement Of Genomic Cancer Testing. Policies Promoting Precision Medicine And Increased Access To Genetic Testing Can Drive Market Growth. 2. Economic: The High Cost Of Genomic Testing And Limited Insurance Coverage Are Key Economic Factors Impacting The Market. However, Advancements In Technology And Increased Competition Are Expected To Drive Down Costs In The Future. 3. Social: Increasing Awareness About The Importance Of Genetic Testing And Personalized Medicine Among Patients And Healthcare Providers Is Contributing To Market Growth. 4. Technological: Rapid Advancements In Genomic Sequencing Technologies, Such As Next-Generation Sequencing, Have Significantly Improved The Accuracy And Efficiency Of Genomic Cancer Testing. D) Key Takeaways: 1: The Global Genomic Cancer Testing Market Is Expected To Witness High Growth, Exhibiting A CAGR Of 16.1% Over The Forecast Period, Due To Increasing Demand For Personalized Medicine. With The Ability To Analyze An Individual's Genetic Profile, Genomic Cancer Testing Enables Tailored Treatment Plans And Improves Patient Outcomes. 2: North America Is Anticipated To Dominate The Genomic Cancer Testing Market, Owing To The Presence Of Leading Market Players, Favorable Reimbursement Policies, And Increasing Adoption Of Precision Medicine In The Region. 3: Key Players Operating In The Global Genomic Cancer Testing Market Include Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc. (Roche), Invitae Corporation, Neogenomics Laboratories, Inc., Myriad Genetics, Inc., Genomic Health, Inc. (Exact Sciences Corporation), Caris Life Sciences, Archerdx, Inc. (Invitae Corporation), Guardant Health, Inc., Personal Genome Diagnostics Inc., Biocept, Inc., And Tempus Labs, Inc. In Conclusion, The Global Genomic Cancer Testing Market Is Expected To Witness Significant Growth In The Coming Years, Driven By The Increasing Demand For Personalized Medicine And Advancements In Genomic Sequencing Technologies. Adoption Of Precision Medicine And Supportive Government Policies Are Key Factors That Will Contribute To Market Expansion.

[market-insider]

Consumer Genomics Market: Exploring the Genetic Ancestry and Health Insights

Consumer genomics refers to the use of genetic testing and analysis technologies to provide individuals with information about their genetic makeup and ancestry. It involves direct-to-consumer genetic testing services that allow individuals to obtain insights into their genetic traits, health predispositions, and ancestral origins. Consumer genomics services provide individuals with information about their ethnic origins, regional ancestry, and migration patterns based on genetic markers. Users can trace their ancestral lineage and discover connections to different populations around the world. It enables individuals to learn about their genetic predispositions to certain health conditions or traits. It can provide insights into genetic risks for diseases such as diabetes, cardiovascular conditions, and certain types of cancer. This information can empower individuals to make informed decisions about their lifestyle, diet, and preventive healthcare. Pharmacogenomic testing analyzes an individual's genetic variants to predict how they may respond to certain medications. Consumer genomics can provide users with information about which medications may be more or less effective for them, helping to optimize drug selection and dosage. Consumer genomics services often provide fun and informative insights into various genetic traits such as eye color, hair texture, lactose intolerance, and taste preferences. These features add an element of entertainment and personal curiosity to genetic testing. It allow users to connect with relatives and build family trees based on shared genetic information. They can discover previously unknown relatives, explore genetic relationships, and build a more comprehensive understanding of their family history.

Gain deeper insights on the market and receive your free copy with TOC now @: Consumer Genomics Market Report

The global consumer genomics market size is projected to reach USD 8.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.4% from 2021 to 2028. Consumer genomics companies are increasingly focusing on providing health-related genetic testing services. This includes identifying genetic predispositions for various health conditions, assessing carrier status for genetic diseases, and offering pharmacogenomic insights to personalize medication selection and dosing. The integration of AI and ML technologies is enabling consumer genomics companies to analyze large-scale genetic data sets more efficiently and accurately. These technologies help in identifying patterns, predicting disease risks, and providing more personalized recommendations based on an individual's genetic profile. Consumer genomics companies are placing greater emphasis on privacy and data security due to the sensitivity of genetic information. They are implementing stricter security measures and providing clearer consent processes to ensure that customer data is protected. Major companies are forming collaborations with healthcare providers and pharmaceutical companies to leverage genetic data for research and drug development purposes. These partnerships aim to accelerate the discovery of new treatments, improve patient outcomes, and advance precision medicine initiatives.

Consumer genomics services are increasingly integrating with digital health platforms and mobile applications. This integration allows users to access and manage their genetic information conveniently, receive personalized health recommendations, and connect with healthcare professionals or genetic counselors for further guidance. Top companies continue to refine their genealogy and family connection features. They are enhancing their databases, algorithms, and tools to enable users to connect with relatives, build family trees, and explore their genetic heritage more comprehensively. Companies are investing in educational initiatives to enhance genetic literacy among the general public. They are providing educational resources, webinars, and interactive tools to help users understand genetic testing results and make informed decisions about their health.

[neha24blog]

Single-Cell Genome Sequencing Market Focusing On The Basis Of Products, Disease Type, Region And Forecast 2025: Grand View Research Inc.

San Francisco, 2 May 2023: The Report Single-Cell Genome Sequencing Market Size, Share & Trends Analysis Report By Product, By Technology (PCR, NGS, qPCR), By Workflow, By Application, By Disease Area, By End Use, And Segment Forecasts, 2018 – 2025 The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025, according to a new report by Grand View Research,…

[mariacallous]

Like so many of us, I was dispirited to wake up a few weeks ago to learn that Donald Trump will be back in the White House. This time he was aided by the world’s richest man and professional spaceship-crasher, Elon Musk. Among the many charming aspects of their partnership is a fondness for some highly unsavoury views on genetics. Trump is an enthusiastic advocate of “racehorse theory”, which he shares with white supremacists; the belief that he is personally superior and that this is rooted in his “good genes”. It’s a vapid idea, but it directly informs his toxic views on immigration, where he argues the country needs to be shielded from the “bad genes”of outsiders.

Meanwhile, Musk has his own equally baffling take on genetics, infused with a characteristic messiah complex. Like some of his fellow tech moguls, he is determined to “save humanity” by producing as many offspring as possible, convinced that our future depends on it. This might all be laughable were it not for the fact that Trump and Musk now wield more power than they ever have before. The shared thread running through their rhetoric is genetic determinism: the idea that who you are, and what you can achieve, is all down to your DNA. Nothing else matters.

The problem is that genetic determinism, with its odd fixation on the “master molecule”, is annoyingly pervasive. When James Watson and Francis Crick discovered the structure of DNA in 1953, they hailed it as the “secret of life”. In 2000, President Bill Clinton declared that sequencing the human genome was like learning “the language in which God created life”. Of course, science always carries the potential to be this thrilling; I don’t want to kill anyone’s science buzz. But I worry that in all the excitement, we can forget that DNA does not define us.

This language has leaked far outside the world of science, to marketing that raves about cars “with adventure in their DNA”, or a discussion of a football club’s “DNA” – it has become a synonym for everything from “characteristics” to “values”. The ubiquity of rhetoric that conflates DNA and identity risks propping up some insidious ideas. This is the language Musk and Trump thrive on, making exclusionary policies look like rational decisions grounded in science. Because, if genes are everything, why bother with policies aimed at tackling inequality? Why waste time and resources addressing social problems when we’re all just products of our genetic code?

In debates surrounding genetics and social policy, it is easy for the language of genetic determinism to lure you into an ill-advised “nature v nurture” debate. You know this debate: maybe she’s born with it; maybe it’s the pervasive conditions of social inequality? But this debate misses the bigger picture entirely: it should not be seen as a binary choice. The truth is, humans are born with genes that require a good environment to thrive. It’s not either/or, but a complex interaction between the two that determines who someone becomes. We have a nature that requires nurture. Good science accounts for this complexity, rather than reducing it to a simplistic binary.

Along with making it harder to argue for progressive social policies, genetic determinism also has a long history of being used to justify violence, particularly by the far right. In 2022, a gunman in Buffalo, New York, cited genetics as part of his rationale for a racially motivated mass shooting. The gunman took various scientific ideas, most notably from genetics, but also environmentalism, and blended these with white supremacist conspiracies such as the “great replacement theory”.

The prospect that real-world violence might once again emerge from a warped interpretation of genetic science isn’t just a theoretical concern; it’s a dangerous reality. So how do we stop genetics from being weaponised? It’s not just about calling out dodgy interpretations of the science: in some ways, that’s the easy part. The harder question involves emotions. Why are people – often driven by anger or fear – liable to co-opt genetics to justify their reactionary political ideologies?

In trying to answer this question, one important thing to note is that science is not just a selection of facts, but also a form of culture. As such, it is subject to “cultural poaching”, as the sociologist Michel de Certeau put it – an unauthorised borrowing and re-contextualising of ideas. Take “survival of the fittest”, for example. When Charles Darwin and other evolutionary scientists used that phrase, they had a specific idea of what they meant by “fittest”, and were referring to how well-adapted an organism is to its environment. But in wider culture, the idea has taken on a life of its own, whereby “fittest” is just a synonym for “best”, or “strongest” – the phrase is often deployed to give bigoted ideas a scientific veneer.

There is evidence that some on the far right are tracking particular academic fields and broadcasting flawed interpretations of scholarly research papers as soon as they are available. Rightly wary of this kind of activity, some scientists are now publishing journal articles discussing how to stop genetics being co-opted by extremists, while science ethics organisations such as Cera provide resources to the same end.

With figures such as Trump and Musk wielding huge power, and the “alt-right” keyboard warriors helping them spread disinformation, genetic science has been forced to the frontline. As uncomfortable as it might be, it is more urgent than ever for people working in the field to ask: “How might my work be poached, and what can I do to stop it?”